232
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Deciphering the impact of missense mutations on structure and dynamics of SMAD4 protein involved in pathogenesis of gall bladder cancer

ORCID Icon, , ORCID Icon, , , , , & show all
Pages 1940-1954 | Received 18 Jul 2019, Accepted 04 Mar 2020, Published online: 17 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elaheh Mohammadnejadi & Nima Razzaghi-Asl. (2023) In silico target specific design of potential quinazoline-based anti-NSCLC agents. Journal of Biomolecular Structure and Dynamics 41:20, pages 10725-10736.
Read now
Kaishiv Joshi, Satbir Kaur & Rakesh Kumar. (2022) Cytochrome P450 2C19 gene polymorphisms (CYP2C19*2 and CYP2C19*3) in chronic myeloid leukemia patients: in vitro and in silico studies. Journal of Biomolecular Structure and Dynamics 40:19, pages 9389-9402.
Read now

Articles from other publishers (3)

Rahul Kumar, Rakesh Kumar, Harsh Goel, Sonu Kumar, Somorjit Singh Ningombam, Imran Haider, Usha Agrawal, Svs Deo, Ajay Gogia, Atul Batra, Ashok Sharma, Sandeep Mathur, Amar Ranjan, Anita Chopra, Showket Hussain & Pranay Tanwar. (2023) Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population. Cancer Cell International 23:1.
Crossref
Rakesh Kumar, Rahul Kumar & Pranay Tanwar. (2021) Structural based screening of potential inhibitors of SMAD4: a step towards personalized medicine for gall bladder and other associated cancers. Molecular Diversity 25:3, pages 1945-1961.
Crossref
Arif Ali, Muhammad Tahir Khan, Abbas Khan, Sajid Ali, Sathishkumar Chinnasamy, Khalid Akhtar, Athar Shafiq & Dong-Qing Wei. (2020) Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior . RSC Advances 10:58, pages 35565-35573.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.